(Q37638759)

21 August 2017

1 reference

title

Drugs in the medical treatment of Cushing's syndrome (English)

1 reference

21 August 2017

David E Schteingart

1

1 reference

PubMed ID

19939210

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Emerging Drugs

21 August 2017

1 reference

21 August 2017

14

1 reference

21 August 2017

4

1 reference

21 August 2017

661-671

1 reference

Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Long term control of hypercortisolism with fluconazole: case report and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Aminoglutethimide in the treatment of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Successful control of Cushing's disease in the elderly with long term metyrapone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Metyrapone Is Useful Only as Adjunctive Therapy in Cushing's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Sustained Remission of Cushing's Disease with Mitotane and Pituitary Irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Metabolic activation and binding of mitotane in adrenal cortex homogenates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Comparison of the adrenalytic activity of mitotane and a methylated homolog on normal adrenal cortex and adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Treatment of Cushing's Syndrome with Trilostane (WIN 24,540), an Inhibitor of Adrenal Steroid Biosynthesis*

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Ectopic ACTH-producing tumors of the chest and octreotide scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Octreotide and the novel multireceptor ligand somatostatin receptor agonist pasireotide (SOM230) block the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Merits and pitfalls of mifepristone in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Cabergoline plus lanreotide for ectopic Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

Propranolol Therapy for Ectopic β-Adrenergic Receptors in Adrenal Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728210903413522

10.1517/14728210903413522

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19939210